Orgentec Diagnostika

Mainz, Germany Founded: 2009 • Age: 17 yrs Acquired By Sebia
Diagnostics tools for Autoimmune and Infectious Diseases
Request Access

About Orgentec Diagnostika

Orgentec Diagnostika is a company based in Mainz (Germany) founded in 2009 was acquired by Sebia in July 2020.. Orgentec Diagnostika has completed 1 acquisition, including Corgenix. Orgentec Diagnostika offers products and services including Alegria, ELISA, and Immunfluoreszenz.

  • Headquarter Mainz, Germany
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Orgentec Diagnostika Gmbh
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $392.96 (USD), Grant

    Feb 01, 2017

  • Investors
    Sebia

    & 2 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Sebia

    (Jul 01, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Orgentec Diagnostika

Orgentec Diagnostika offers a comprehensive portfolio of products and services, including Alegria, ELISA, and Immunfluoreszenz. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

System for testing autoimmune and infectious diseases in laboratories

Assay method for detecting antibodies in infectious and autoimmune conditions

Fluorescence-based method for identifying disease markers in diagnostics

People of Orgentec Diagnostika
Headcount 50-200
Employee Profiles 4
Employee Profiles
People
Dr. Natalia Kuzmina
Area Manager Eastern Europe & Central Asia
People
Michael Funk
Finance Director

Unlock access to complete

Funding Insights of Orgentec Diagnostika

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $393
  • First Round
  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2017 Amount Grant - Orgentec Diagnostika Valuation

investors

May, 2014 Amount Private Equity Round - Orgentec Diagnostika Valuation

investors

Jan, 2014 Amount Grant - Orgentec Diagnostika Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Orgentec Diagnostika

Orgentec Diagnostika has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Sebia, European Union and Water Street. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Water Street is engaged in strategic investments in healthcare sectors.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Electrophoresis-based in vitro diagnostics products are developed and provided.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Orgentec Diagnostika

Orgentec Diagnostika has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Corgenix. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Diagnostic tests for vascular diseases are developed and supplied.
1990
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Orgentec Diagnostika

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Orgentec Diagnostika Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Orgentec Diagnostika

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Orgentec Diagnostika

Frequently Asked Questions about Orgentec Diagnostika

When was Orgentec Diagnostika founded?

Orgentec Diagnostika was founded in 2009 and raised its 1st funding round 5 years after it was founded.

Where is Orgentec Diagnostika located?

Orgentec Diagnostika is headquartered in Mainz, Germany. It is registered at Mainz, Rhineland-palatinate, Germany.

Who is the current CEO of Orgentec Diagnostika?

James Widergren is the current CEO of Orgentec Diagnostika.

What does Orgentec Diagnostika do?

ORGENTEC develops, manufactures and markets in-vitro diagnostic products for clinical labs. The company offers more than 200 highly specific ELISA test systems, blot and immunofluorescence tests for the diagnosis of Autoimmune and Infectious Diseases. In addition, the company offers fully automatic analyzer Alegria, stool diagnostic products (Alpha-1-Antitrypsin test, Calprotectin test, lactoferrin test, Stool Extraction medium, Stool Extraction Tubes, and Stool Sample Collector) and 25-OH vitamin D 3 D 2 ELISA test. Its rapid test rheumachec is a lateral flow test that allows detection of combined rheumatoid factors (RF) and autoantibodies against mutated citrullinated vimentin (anti-MCV ) in a whole blood sample.

What products or services does Orgentec Diagnostika offer?

Orgentec Diagnostika offers Alegria, ELISA, and Immunfluoreszenz.

How many acquisitions has Orgentec Diagnostika made?

Orgentec Diagnostika has made 1 acquisition, including Corgenix.

Who are Orgentec Diagnostika's investors?

Orgentec Diagnostika has 3 investors. Key investors include Sebia, European Union, and Water Street.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available